Uncategorized
Aerie Pharmaceuticals Announces Appointment of Lily Nguyen as Director, Project Management
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced the appointment of Lily Nguyen as Director, Project Management, reporting to Kenneth Ruettimann, Ph.D., Aerie’s Vice President of Manufacturing. Ms. Nguyen will direct strategic plan development and